New Offices Now Open in the Philadelphia Navy Yard & Reading - We are scheduling new and existing patients.
Carl Regillo, MD was interviewed by MD Magazine to discuss the clinical usage of the new anti-VEGF injection treatment, brolucizumab (Beovu), that has been approved by the FDA for the treatment of Wet Macular Degeneration.
Carl Regillo, MD was interviewed by MD Magazine to discuss the clinical usage of the new anti-VEGF injection treatment, brolucizumab (Beovu), that has been approved by the FDA for the treatment of Wet Macular Degeneration.